GLP-1 reduces rates of post-bariatric hypoglycemia
A once-daily GLP-1 receptor agonist decreased events of level 2 and level 3 hypoglycemia for adults after Roux-en-Y gastric bypass, according to topline results from a phase 3 tria...
Search fresh public links, source activity, and ready-to-use post angles for Post-Bariatric Hypoglycemia.
Fresh curated links around post-bariatric hypoglycemia are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
A once-daily GLP-1 receptor agonist decreased events of level 2 and level 3 hypoglycemia for adults after Roux-en-Y gastric bypass, according to topline results from a phase 3 tria...
Amylyx Pharmaceuticals’ avexitide led to statistically significant and clinically meaningful reductions in hypoglycemic events in patients with post-bariatric hypoglycemia (PBH). T...
Preoperative GLP-1 receptor agonist use did not impact bariatric surgery outcomes, including weight loss at 1 year, diabetes control and postsurgical complications, according to a...
A common complication of early birth is being thrust into a medical debate that reaches far beyond the neonatal intensive-care unit: how low is too low when a late preterm baby’s b...
A retrospective analysis of more than 200,000 adolescents and young adults treated for obesity shows a significant increase in GLP-1 receptor agonist use since 2022, with a corresp...
Bariatric surgery may confer greater long-term weight loss than semaglutide or tirzepatide for adults with obesity, according to data from a real-world study published in Obesity.K...
Restarting obesity medications, including glucagon-like peptide-1 (GLP-1) receptor agonists, soon after sleeve gastrectomy (SG) is associated with greater one-year weight loss than...
A duodenal mucosal resurfacing procedure may help adults with obesity maintain weight loss 1 year after discontinuing obesity pharmacotherapy, according to topline results from the...
Vogenx’s mizagliflozin is heading into Phase 2b testing for post-bariatric hypoglycemia (PBH). Amylyx Pharmaceuticals and Recordati are developing injectable peptide drugs for this...
A simple post-meal habit may help keep blood sugar on track.
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.